KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $219.0 million.

  • Gilead Sciences' Change in Acquisitions & Divestments changed N/A to $219.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $514.0 million, marking a year-over-year decrease of 8033.66%. This contributed to the annual value of $2.3 billion for FY2024, which is 6979.01% up from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Change in Acquisitions & Divestments is $219.0 million.
  • Gilead Sciences' Change in Acquisitions & Divestments' 5-year high stood at $2.3 billion during Q1 2024, with a 5-year trough of $219.0 million in Q3 2025.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $372.0 million (2021), whereas its average is $525.5 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first tumbled by 9657.84% in 2021, then surged by 59907.41% in 2024.
  • Over the past 5 years, Gilead Sciences' Change in Acquisitions & Divestments (Quarter) stood at $372.0 million in 2021, then dropped by 3.76% to $358.0 million in 2022, then decreased by 2.51% to $349.0 million in 2023, then soared by 549.0% to $2.3 billion in 2024, then plummeted by 90.33% to $219.0 million in 2025.
  • Its Change in Acquisitions & Divestments was $219.0 million in Q3 2025, compared to $295.0 million in Q2 2025 and $2.3 billion in Q1 2024.